Keros Therapeutics ($KROS) Insider Trading & Smart Money Activity

Keros Therapeutics, Inc. · Biotechnology · Latest filing Jun 15, 2026

Keros Therapeutics, Inc. ($KROS) has 2 insider trades on file. In the last 12 months on the open market, 1 insider bought ($10.19K) and 1 insider sold ($5.52K), net +$4.67K.

Insider buyers (12 mo): 1
Insider sellers (12 mo): 1
Net insider $ (12 mo): +$4.67K
Congress trades (12 mo): 0
13F moves on file: 0
Analyst ratings on file: 0

KROS insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	1 · $10.19K	1 · $5.52K	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All KROS insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 15, 2026	Insider	Bienaime Jean Jacques	Buy (Open-market buy) 10b5-1	1K sh	$10.19K		+7.2%	+7.7%			—
Jun 11, 2026	Insider	Charles Newton	Sell (Open-market sale) 10b5-1	550 sh	$5.52K		+6.0%	+10.4%			Read

1W / 1M / 6M = how KROS moved from the trade or filing date.

Insider trading in KROS: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Bienaime Jean Jacques		1	+$10.19K		Jun 15, 2026
Charles Newton		1	-$5.52K		Jun 11, 2026

Frequently asked questions

Are KROS insiders buying or selling?

Over the last 12 months 1 insider made 1 open-market purchase worth $10.19K and 1 insider made 1 open-market sale worth $5.52K, a net +$4.67K.

What is the latest insider trade in KROS?

Bienaime Jean Jacques filed a buy (open-market buy) of 1K sh worth $10.19K on Jun 15, 2026.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text